Corning Life Sciences and Emerging Growth Businesses — Other segment items decreased by 1.2% to $249.00M in Q1 2026 compared to the prior quarter.
Large fluctuations may indicate non-recurring events or operational adjustments that require further investigation.
This metric captures miscellaneous income or expense items specific to the Life Sciences and Emerging Growth segment tha...
Comparable to 'other operating income/expense' line items found in segment reporting for diversified conglomerates.
glw_segment_life_sciences_and_emerging_growth_businesses_other_segment_items| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $252.00M | $249.00M |
| QoQ Change | — | -1.2% |
| YoY Change | — | -1.2% |